BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 12/06/2007

FDA Reclassifies Intervertebral Body Fusion Devices

The FDA is reclassifying intervertebral body fusion devices with bone grafting material from class III to class II, and those with therapeutic biologics from class III to class II, based on the recommendation of the Orthopaedic and Rehabilitation Devices Panel.

Source: Federal Register — Food and Drug AdministrationOpen original release →